These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 7674501)

  • 21. Aggregate cost of mammography screening in the United States: comparison of current practice and advocated guidelines.
    O'Donoghue C; Eklund M; Ozanne EM; Esserman LJ
    Ann Intern Med; 2014 Feb; 160(3):145. PubMed ID: 24658691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of mammographic screening in Australia.
    Carter R; Glasziou P; van Oortmarssen G; de Koning H; Stevenson C; Salkeld G; Boer R
    Aust J Public Health; 1993 Mar; 17(1):42-50. PubMed ID: 8357894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of alternative practices on the cost and quality of mammographic screening in the United States.
    Burnside E; Belkora J; Esserman L
    Clin Breast Cancer; 2001 Jul; 2(2):145-52. PubMed ID: 11899786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mammography screening: a new estimate of number needed to screen to prevent one breast cancer death.
    Hendrick RE; Helvie MA
    AJR Am J Roentgenol; 2012 Mar; 198(3):723-8. PubMed ID: 22358016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effective mammography screening in Korea: high incidence of breast cancer in young women.
    Lee SY; Jeong SH; Kim YN; Kim J; Kang DR; Kim HC; Nam CM
    Cancer Sci; 2009 Jun; 100(6):1105-11. PubMed ID: 19320639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of recommendations for screening mammography using CISNET models.
    Arleo EK; Hendrick RE; Helvie MA; Sickles EA
    Cancer; 2017 Oct; 123(19):3673-3680. PubMed ID: 28832983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Continuing screening mammography in women aged 70 to 79 years: impact on life expectancy and cost-effectiveness.
    Kerlikowske K; Salzmann P; Phillips KA; Cauley JA; Cummings SR
    JAMA; 1999 Dec; 282(22):2156-63. PubMed ID: 10591338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. United States Preventive Services Task Force screening mammography recommendations: science ignored.
    Hendrick RE; Helvie MA
    AJR Am J Roentgenol; 2011 Feb; 196(2):W112-6. PubMed ID: 21257850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of breast cancer screening in women on dialysis.
    Wong G; Howard K; Chapman JR; Craig JC
    Am J Kidney Dis; 2008 Nov; 52(5):916-29. PubMed ID: 18789566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The value of mammography screening in women under age 50 years.
    Eddy DM; Hasselblad V; McGivney W; Hendee W
    JAMA; 1988 Mar; 259(10):1512-9. PubMed ID: 3123720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insights Into Breast Cancer Screening: A Computer Simulation of Two Contemporary Screening Strategies.
    Carter KJ; Castro F; Morcos RN
    AJR Am J Roentgenol; 2018 Mar; 210(3):564-571. PubMed ID: 29323554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcome analysis for women undergoing annual versus biennial screening mammography: a review of 24,211 examinations.
    Hunt KA; Rosen EL; Sickles EA
    AJR Am J Roentgenol; 1999 Aug; 173(2):285-9. PubMed ID: 10430120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The cost-effectiveness of screening mammography beyond age 65 years: a systematic review for the U.S. Preventive Services Task Force.
    Mandelblatt J; Saha S; Teutsch S; Hoerger T; Siu AL; Atkins D; Klein J; Helfand M;
    Ann Intern Med; 2003 Nov; 139(10):835-42. PubMed ID: 14623621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.
    Saadatmand S; Tilanus-Linthorst MM; Rutgers EJ; Hoogerbrugge N; Oosterwijk JC; Tollenaar RA; Hooning M; Loo CE; Obdeijn IM; Heijnsdijk EA; de Koning HJ
    J Natl Cancer Inst; 2013 Sep; 105(17):1314-21. PubMed ID: 23940285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Total cost-effectiveness of mammography screening strategies.
    Mittmann N; Stout NK; Lee P; Tosteson AN; Trentham-Dietz A; Alagoz O; Yaffe MJ
    Health Rep; 2015 Dec; 26(12):16-25. PubMed ID: 26676235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-Effectiveness of Screening Mammography Beyond Age 75 Years : A Cost-Effectiveness Analysis.
    Schousboe JT; Sprague BL; Abraham L; O'Meara ES; Onega T; Advani S; Henderson LM; Wernli KJ; Zhang D; Miglioretti DL; Braithwaite D; Kerlikowske K
    Ann Intern Med; 2022 Jan; 175(1):11-19. PubMed ID: 34807717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost effectiveness of mammography screening for Chinese women.
    Wong IO; Kuntz KM; Cowling BJ; Lam CL; Leung GM
    Cancer; 2007 Aug; 110(4):885-95. PubMed ID: 17607668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a protocol for evaluation of mammographic surveillance services in women under 50 with a family history of breast cancer.
    Mackay J; Rogers C; Fielder H; Blamey R; Macmillan D; Boggis C; Brown J; Pharoah PD; Moss S; Day NE; Myles J; Austoker J; Gray J; Cuzick J; Duffy SW
    J Epidemiol Biostat; 2001; 6(5):365-9; discussion 371-5. PubMed ID: 11822726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DOES ONE SIZE FIT ALL? COST UTILITY ANALYSES OF ALTERNATIVE MAMMOGRAPHIC FOLLOW-UP SCHEDULES, BY RISK OF RECURRENCE.
    Bessen T; Keefe DM; Karnon J
    Int J Technol Assess Health Care; 2015 Jan; 31(5):281-8. PubMed ID: 26654334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk- and cost-benefit analyses of breast screening programs derived from absorbed dose measurements in The Netherlands.
    Zuur C; Broerse JJ
    Diagn Imaging Clin Med; 1985; 54(3-4):211-22. PubMed ID: 3928229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.